Research Article18210.1016/j.vaccine.2007.04.008Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein–Barr virus vaccine in healthy adultsApr 18, 2007VaccineMichel Moutschen + 10 more +10RelevantCiteListenSave